Canaccord: Tilt Holdings' Massachusetts Rollout Slower Than Expected

Canaccord Genuity is staying bullish on vertically integrated Canadian company TILT Holdings Inc SVVTF after its first-quarter print. 

The Analysts

Bobby Burleson reiterated a Speculative Buy rating on Tilt Holdings with a CA$4 ($2.97) price target. 

Need more cannabis news? Check out all of our coverage here.

The Thesis

"While nothing from the release or Q&A was meaningfully different from our expectations, out of an abundance of caution, we are shifting some revenue (a couple million) from Q2 to the back half of the year, primarily in Massachusetts," Burleson said of the company's May 30 quarterly report. (See his track record here.) 

The company's rollout in Massachusetts has been slower than anticipated, the analyst said. 

The slow rollout coupled with high spending levels to develop the business resulted in Tilt reporting first-quarter 2019 earnings of $34.4 million in revenue with negative $8 million EBITDA, Burleson said. 

Canaccord expects business to uptick in Massachusetts during the second half of 2019 and into 2020, and said this trend should coincide with lower levels of spending in the state as well as the granting of additional licenses.

Price Action

Over-the-counter Tilt Holdings shares were down 13.43 percent at $1.16 at the time of publication Monday. 

Related Links:

Canaccord Genuity Turns Bullish On The Green Organic Dutchman After Sell-Off

TILT Holdings Targets 'Every Stage Of The Cannabis Supply Chain' With M&A Strategy

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorCannabisEarningsNewsPrice TargetReiterationMarketsAnalyst RatingsBobby BurlesonCanaacord Genuitymarijuanapotweed
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...